Incidence and risk factors associated with development of clinical cardiotoxicity in dogs receiving doxorubicin

Arrhythmogenic Right Ventricular Cardiomyopathy in the Boxer Dog

(2017) Kathryn M. Meurs   VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE

Noninvasive early detection of anthracycline-induced cardiotoxicity in patients with hematologic malignancies using the phased tracking method

(2016) Yoshiko Saito et al.   Cancer Medicine

Prevention of Anthracycline-Induced Cardiotoxicity

(2014) Pimprapa Vejpongsa et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Expert Consensus for Multimodality Imaging Evaluation of Adult Patients during and after Cancer Therapy: A Report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

(2014) Juan Carlos Plana et al.   JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY

Dexrazoxane treatment of doxorubicin extravasation injury in four dogs

(2012) Rachel O. Venable et al.   JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION

Safety of concurrent administration of dexrazoxane and doxorubicin in the canine cancer patient*

(2010) W. M. FitzPatrick et al.   Veterinary and Comparative Oncology

Sudden Death in a Dog After Doxorubicin Chemotherapy

(2010) B. Banco et al.   VETERINARY PATHOLOGY

Dexrazoxane (TotectTM): FDA Review and Approval for the Treatment of Accidental Extravasation Following Intravenous Anthracycline Chemotherapy

(2008) R. C. Kane et al.   ONCOLOGIST